CLN2 DISEASE EDUCATIONAL WEBINAR SERIES
The importance of early genetic testing in pediatric epilepsy
Insights from the CLN2 disease experience
PLAY IN ENGLISH
DOWNLOAD SLIDES IN ENGLISH STAY INFORMED
If you wish to stay informed about other CLN2 disease resources
please register via the button above.
|Epilepsy and Genetics||Raman Sankar|
|CLN2 Disease and the Need for Early Diagnosis||Nicola Specchio|
|Genetic Testing and Actionability of Results||Raman Sankar|
|Case Study||Nicola Specchio|
What you will learn
Genetic research is rapidly advancing our understanding of the underlying causes of epilepsy. Early genetic testing in pediatric epilepsy patients can help uncover devastating disorders, like CLN2 disease, earlier in the course of the disease. Learn more about diagnostic testing options which could uncover the underlying cause of a seizure. A definitive diagnosis can enable more precise clinical management and improve patient outcomes, in some cases.
This program is developed for healthcare professionals interested in learning about the importance of genetic testing in pediatric epilepsy patients.
No CME credit will be offered for this webinar
This webinar was developed and funded by BioMarin